A comprehensive analysis of decades of brain-chemistry research has identified a consistent biological marker across several anxiety disorders: reduced levels of choline-containing compounds in key brain regions. The findings, published in Molecular Psychiatry, suggest a measurable chemical difference that may improve scientific understanding of how anxiety develops and how it might eventually be treated.
Anxiety disorders—including generalized anxiety disorder, panic disorder, and social anxiety disorder—are the most common mental health conditions in the United States, affecting nearly one in three adults. According to senior author Dr. Richard Maddock of the University of California, Davis, these conditions can substantially impair daily functioning, and many people do not receive effective treatment.
How Anxiety Affects Brain Circuits
Anxiety disorders arise from disruptions in brain circuits responsible for detecting threats and regulating emotional responses. Structures such as the amygdala, which evaluates danger, and the prefrontal cortex, which helps manage stress and decision-making, may become overactive or poorly coordinated. This can cause everyday challenges to feel overwhelming, leading to persistent worry or heightened vigilance.
Choline is an essential nutrient involved in cell-membrane integrity and the production of neurotransmitters that support memory and mood regulation. Most choline must be obtained through diet, and deficiencies can affect neural function.
Meta-Analysis Reveals Consistent Choline Reduction
Maddock and co-author Jason Smucny conducted a meta-analysis of 25 independent studies using proton magnetic resonance spectroscopy, a noninvasive technique that measures chemical concentrations in specific brain regions. Their combined dataset included 370 individuals with anxiety disorders and 342 without.
Across studies, people with anxiety disorders showed an average 8% reduction in cortical choline levels. While the decrease may appear modest, the authors note that small chemical changes can meaningfully influence brain activity. The reduction was most consistent in the prefrontal cortex, an area central to emotional regulation and executive function.
The pattern was “transdiagnostic,” appearing across multiple anxiety conditions rather than being tied to any single diagnosis. The association also persisted after accounting for factors such as age, medication status, and technical differences among imaging protocols. In studies with the most precise measurements, the magnitude of choline reduction was even clearer.
The researchers additionally observed a small but significant decrease in N-acetylaspartate, a marker of neuronal integrity, after removing statistical outliers. This may indicate broader metabolic or structural changes in the brains of people with anxiety.
Diet, Stress, and Unanswered Questions
Chronic activation of the body’s stress-response system may increase the brain’s demand for choline, gradually lowering available levels. However, they emphasize that the findings show correlation, not causation. It remains unknown whether reduced choline contributes to anxiety symptoms or if anxiety-related processes lead to choline depletion.
Still, the results raise the possibility that nutritional strategies—such as ensuring adequate dietary choline—could support standard treatments. Choline-rich foods include eggs, salmon, beef, chicken, soybeans, and certain legumes. Maddock cautions against self-prescribing high-dose supplements, noting that clinical trials are needed to determine whether dietary changes or supplementation can reduce anxiety symptoms.
Related topics
